Skip to main content
Elsevier

Journals in Oncology

Focusing on tumor biology, diagnostics, and targeted therapies, this portfolio supports oncologists, researchers, and clinicians. It features innovations that improve cancer detection, personalized treatments, and survivorship care.

  • Cellular Signalling

    • ISSN: 0898-6568
    Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.
    Subscriptions

  • Medical Image Analysis

    • ISSN: 1361-8415
    An official journal of the MICCAI SocietyMedical Image Analysis provides a forum for the dissemination of new research results in the field of medical and biological image analysis, with special emphasis on efforts related to the applications of computer vision, virtual reality and robotics to biomedical imaging problems. The journal publishes the highest quality, original papers that contribute to the basic science of processing, analysing and utilizing medical and biological images for these purposes. The journal is interested in approaches that utilize biomedical image datasets at all spatial scales, ranging from molecular/cellular imaging to tissue/organ imaging. While not limited to these alone, the typical biomedical image datasets of interest include those acquired from:Magnetic resonanceUltrasoundC... tomographyNuclear medicineX-rayOptical and Confocal MicroscopyVideo and range data imagesThe types of papers accepted include those that cover the development and implementation of algorithms and strategies based on the use of various models (geometrical, statistical, physical, functional, etc.) to solve the following types of problems, using biomedical image datasets: representation of pictorial data, visualization, feature extraction, segmentation, inter-study and inter-subject registration, longitudinal / temporal studies, image-guided surgery and intervention, texture, shape and motion measurements, spectral analysis, digital anatomical atlases, statistical shape analysis, computational anatomy (modelling normal anatomy and its variations), computational physiology (modelling organs and living systems for image analysis, simulation and training), virtual and augmented reality for therapy planning and guidance, telemedicine with medical images, telepresence in medicine, telesurgery and image-guided medical robots, etc.
    Subscriptions

  • Cytotherapy

    • ISSN: 1465-3249
    Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeuticsDesign of novel therapeutic approaches employing cell/EV/gene productsScientific mechanisms of action of cell/EV/gene therapies in relevant cell-based and pre-clinical modelsScientific mechanisms of action of toxicities attributable to cell/EV/gene therapiesIdentificat... of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response ratesEarly and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapiesImportant advances in cell/EV/gene-based product manufacturing and validationGlobal/reg... regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapiesCytotherapy does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the fieldBasic/translati... studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiologyFunda... scientific studies of normal or pathological processesStudies describing signaling pathways implicated in cancer
    Subscriptions

  • Advances in Oncology

    • ISSN: 2666-853X
    Advances in Oncology highlights the latest findings and updates within the cancer field each year for the practicing oncologist. Advances in Oncology publishes the most current thinking and recent advances from the voice of a truly distinguished editorial board, led by Editor-in-Chief Leonidas C. Platanias, who identify current advances and breakthroughs in the field and invite specialists to contribute original articles on these topics. Topics covered in each volume can include the areas of radiation oncology, surgical oncology, medical oncology, gynecologic oncology, pediatric oncology, neuro-oncology, hemato-oncology, uro-oncology, and gastrointestinal oncology. This series will appeal to all practicing oncologists and will inform and enhance clinical practice.
    Subscriptions

  • Journal of Cancer Policy

    • ISSN: 2213-5383
    In affiliation with European Cancer Organisation Journal of Cancer Policy invites all readers to join the dedicated Twitter channel for the journal: https://twitter.com/... Journal of Cancer Policy is an international journal which publishes research and reviews on global cancer policy. The journal encompasses all aspects of cancer policy from prevention and public health through all modalities of control and cure, palliative care and survivorship including:* Cancer systems and services research * Cancer economics and value-based care * Inequalities in access and outcomes of cancer care * Development and regulatory issues related to cancer drugs, radiotherapy and surgical technologies * Priorities for cancer policy development in low, middle and high income countries * Innovative strategies for prevention, screening and diagnosis of cancer * Development of cancer research and education infrastructure * Social determinants of cancer * The role of trade, globalisation and the law in cancer control * The role of the media and patient advocacy in cancer policy * Policy and social science research germane to cancer * Patient advocacy and information researchThe Journal of Cancer Policy will consider original research, reviews, short communications and reports, and correspondence for publication.
    Subscriptions

  • Clinical Lymphoma, Myeloma & Leukemia

    • ISSN: 2152-2650
    Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
    Subscriptions

  • DNA Repair

    • ISSN: 1568-7864
    DNA Repair (DNAREP) is a journal focusing on DNA repair and cellular responses to DNA damage. DNA Repair publishes articles on genetic, cellular, biochemical, structural, and molecular aspects of DNA repair. The journal welcomes articles describing databases supporting research on DNA repair and responses to DNA damage. The journal will be especially supportive of articles describing novel methods, protocols, and new technologies. Further, the journal is happy to receive articles that report negative results of significance, with mechanisms that may not be fully verified, provided the actual conclusions are justified. Letters to the Editor, hot topics, and classics on DNA repair; historical reflections; book reviews; and meeting reports will also be considered for publication. We are a journal for the DNA repair community and so are happy to report aspects of interest to the community, including obituaries of renowned figures in the field.The journal publishes topics directly pertaining to DNA damage and repair, which includeApoptosisBiol... responses to genomic insultCell cycle regulationCell fate decisionsEpigenetics and chromatinGenomics/bi... diseases: aging, cancer, and neurological dysfunctionImmune responsesMutagenesis and signature mutationsStructural biology and computational modeling
    Subscriptions

  • Cancer Epidemiology

    • ISSN: 1877-7821
    Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).
    Subscriptions

  • Radiotherapy & Oncology

    • ISSN: 0167-8140
    Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation Oncology.Radiotherap... and Oncology, also known as the Green journal, aims at driving innovation in radiation oncology. It publishes high impact articles describing original research as well as review articles. It covers all areas of interest relating to clinical radiotherapy and oncology, medical physics, radiation biology, as well as other areas relevant to the radiation oncology community such as education, health policy, environmental and societal sustainability or health economics. The journal has a particular interest in prospective clinical trials or large population-based database analyses. It also looks to publish works related to: clinical radiotherapy and brachytherapy, combined modality treatment (for example with chemotherapy, surgery and immunology), particle therapy, translational and experimental radiotherapy and radiation biology, medical physics, imaging, dosimetry, and radiation therapy planning, data science and artificial intelligence research relevant to radiotherapy.ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.
    Subscriptions

  • Surgical Oncology

    • ISSN: 0960-7404
    A journal of cancer management & researchSurgical Oncology (SO) is an internationally peer reviewed journal publishing original research both clinical and translational, comprehensive reviews, multimedia articles, and meta-analyses that contribute to the advancement of knowledge in surgical oncology. Occasionally, SO publishes exceptional editorials and commentaries as they relate to selected papers. SO's articles represent a spectrum of current technology in oncology research as well as those concerning clinical trials, surgical technique, methods of investigation and patient evaluation/outcomes.
    Subscriptions

  • Advances in Biological Regulation

    • ISSN: 2212-4926
    Advances in Biological Regulation (formerly Advances in Enzyme Regulation) reports cutting edge scientific progress on regulation at the molecular level, covering:The molecular biology of control of gene expression by hormones, drugs and growth factors in cancer cells and in clinical situations of metabolic diseases, inborn errors of metabolism and neoplasia.Stem cell biology and regenerative medicine issuesRegulatory networks, mainly in cellular signalling, differentiation, cell cycle & growth control, structure-function relationships, cell fate and lineage commitment or assembly mechanisms in cellsViruses, or supramolecular constructs, and signaling mechanisms mediating transcriptionGenomic... proteomic, bioinformatics and systems biology approaches to identify and characterize steps of biological control in cells.Complex cellular, pathogenic, clinical, or animal model systems studied by biochemical, molecular, genetic, epigenetic or quantitative ultrastructural approaches
    Subscriptions

  • Experimental Hematology

    • ISSN: 0301-472X
    Journal for Hematology, Stem Cell Biology and TransplantationOffic... publication of the ISEH - International Society for Experimental HematologyExperiment... Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis and may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment.Articles will be published under the following scientific categories:Stem CellsExperimental Stem Cell TransplantationNorma... HematopoiesisMaligna... HematopoiesisMicroen... and NicheSystems BiologyGenomics/Prot... of HematopoiesisImmunob... and ImmunotherapyGene TherapyClinical InvestigationsNew Techniques and TechnologiesExperime... Hematology publishes two types of articles: Reviews and Perspectives and original findings sub-classified either as Brief Communications of significant singular results and Research Articles presenting the results of more developed studies.Experimental Hematology publishes Special Issues dedicated to important topics in the field. To view our Special Issues and article collections, click here.
    Subscriptions

  • Trends in Cancer

    • ISSN: 2405-8033
    Trends in Cancer is a new member of the Trends review journals, offering concise and engaging expert commentary articles that address key frontline research topics and cutting-edge advances in the rapidly changing field of cancer discovery and medicine. The journal provides a unique platform for multidisciplinary information, discussion and education that is valuable for scientists, clinicians, and policy makers, as well as patients and advocates. The latest opportunities, challenges and potential impact of basic, translational and clinical findings, industry R&D, technology and innovation, ethics, or cancer policy and funding are equally presented and debated in an authoritative but reader-friendly format.Critical issues to be covered in the journal include: adult and pediatric cancers; personalized medicine; tumor microenvironment, resistance and metastasis; immunotherapy; metabolism; genetics and epigenetics; diagnostics, biomarkers and treatment; epidemiology and cancer prevention; cancer related ethics, policy and funding initiatives.
    Subscriptions

  • European Journal of Cancer

    • ISSN: 0959-8049
    Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) publishes high-quality research that advances cancer medicine and patient care. It integrates clinical, translational, preclinical, digital and population-based research, from epidemiology and the biology of cancer through to innovations in cancer treatment and patient care.EJC focuses on the following main cancer research domains:Clinical cancer medicine, including clinical trials from early-phase to phase IV, and real-world data studies in large cohortsClinical-tran... cancer researchPreclinical-... researchDigital cancer medicine, from diagnostics to digital patient care innovationsCancer epidemiologyHealth-r... quality of life (HRQoL) studiesCancer policyWithin its digital oncology scope, the journal welcomes high-quality studies on artificial intelligence, machine learning, computational imaging and pathology, digital biomarkers, real-world data, electronic health record-based research, digital therapeutics, clinical decision support, large language models and other digital health applications relevant to cancer prevention, diagnosis, treatment, survivorship and patient care. The journal prioritises digital and AI studies that are clinically grounded, methodologically robust, transparently reported and appropriately validated, and that consider generalisability, reproducibility, patient safety, privacy, equity and potential sources of bias.EJC does not accept basic science papers. Preclinical studies are considered where they are translational, with clear relevance to clinical application.The journal publishes original research, reviews, current perspectives, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).
    Subscriptions